glp-1 gip gcg Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist GLP-1/GIP/GCG receptor triagonist (IUB447) enhances

They: Slow gastric emptying (food stays in your stomach longer) Increase feelings of fullness Reduce appetite signals While this helps with blood sugar and weight, it can also lead to: Bloating Cramping Pressure or fullness Mild abdominal pain Especially during the first few weeks or after a dose increase

For example, in individuals with obesity undergoing behavioral weight loss interventions, liraglutide administration led to more substantial reductions in global ED psychopathology, shape concerns, and dietary disinhibition compared to those receiving only behavioral weight loss interventions [17, 18]

Mitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in mice

Besides the direct actions to the CNS, GLP-1RAs may exert their action by mitigating and slowing the gastric emptying, which in turn can result in more rapid fullness and reduced alcohol consumption, presumably owing to the fact that alcohol may be conceived as a source of energy [57]

PLoS ONE 8 , e55119 (2013)